New Zealand vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB
New Zealand
100.0%
in 2014
Saint Vincent and the Grenadines
100.0%
in 2023
New Zealand rank
1st
Saint Vincent and the Grenadines rank
1st
New cases tested for RR-/MDR-TB over time
- New Zealand
- Saint Vincent and the Grenadines
How they compare
New Zealand currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2005 it was New Zealand ahead.
New Zealand ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 86.0% | 14.0% | New Zealand |
| 2010s | 80.5% | 56.4% | 24.1% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, New Zealand or Saint Vincent and the Grenadines?
- New Zealand, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2014.
- What is the difference in new cases tested for rr-/mdr-tb between New Zealand and Saint Vincent and the Grenadines?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Saint Vincent and the Grenadines?
- 6 years are reported by both, from 2005 to 2014.
- How do New Zealand and Saint Vincent and the Grenadines rank globally for new cases tested for rr-/mdr-tb?
- New Zealand ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.